Redcare Pharmacy NV (RDC.DE)

EUR 139.9

(-3.38%)

Total Assets Summary of Redcare Pharmacy NV

Redcare Pharmacy NV's latest annual total assets in 2023 was 1.04 Billion EUR , up 43.76% from previous year.
Redcare Pharmacy NV's latest quarterly total assets in 2024 Q2 was 1.02 Billion EUR , up 1.18% from previous quarter.
Redcare Pharmacy NV reported annual total assets of 729.47 Million EUR in 2022, down -6.85% from previous year.
Redcare Pharmacy NV reported annual total assets of 783.07 Million EUR in 2021, up 45.85% from previous year.
Redcare Pharmacy NV reported quarterly total assets of 1.01 Billion EUR for 2024 Q1, down -3.39% from previous quarter.
Redcare Pharmacy NV reported quarterly total assets of 759.95 Million EUR for 2023 Q1, up 4.18% from previous quarter.

Annual Total Assets Chart of Redcare Pharmacy NV (2023 - 2013)

Historical Annual Total Assets of Redcare Pharmacy NV (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	1.04 Billion EUR	43.76%
2022	729.47 Million EUR	-6.85%
2021	783.07 Million EUR	45.85%
2020	536.9 Million EUR	25.45%
2019	427.98 Million EUR	21.96%
2018	350.9 Million EUR	17.83%
2017	297.8 Million EUR	147.45%
2016	120.35 Million EUR	181.38%
2015	42.77 Million EUR	44.95%
2014	29.5 Million EUR	14.73%
2013	25.72 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	1.02 Billion EUR	1.18%
2024 Q1	1.01 Billion EUR	-3.39%
2023 Q1	759.95 Million EUR	4.18%
2023 Q2	1.09 Billion EUR	44.32%
2023 Q4	1.04 Billion EUR	-4.23%
2023 FY	1.04 Billion EUR	43.76%
2023 Q3	1.09 Billion EUR	-0.15%
2022 Q4	729.47 Million EUR	-5.14%
2022 Q1	774.61 Million EUR	-1.08%
2022 Q2	787.23 Million EUR	1.63%
2022 FY	729.47 Million EUR	-6.85%
2022 Q3	768.96 Million EUR	-2.32%
2021 Q4	783.07 Million EUR	-3.17%
2021 Q3	808.74 Million EUR	-1.04%
2021 Q2	817.23 Million EUR	-2.1%
2021 Q1	834.79 Million EUR	55.48%
2021 FY	783.07 Million EUR	45.85%
2020 FY	536.9 Million EUR	25.45%
2020 Q4	536.9 Million EUR	-2.36%
2020 Q3	549.87 Million EUR	0.92%
2020 Q2	544.87 Million EUR	16.23%
2020 Q1	468.77 Million EUR	9.53%
2019 Q3	450.8 Million EUR	-1.14%
2019 Q4	427.98 Million EUR	-5.06%
2019 FY	427.98 Million EUR	21.96%
2019 Q1	353.95 Million EUR	0.87%
2019 Q2	456.01 Million EUR	28.84%
2018 Q1	297.15 Million EUR	-0.22%
2018 FY	350.9 Million EUR	17.83%
2018 Q4	350.9 Million EUR	-3.56%
2018 Q3	363.87 Million EUR	1.37%
2018 Q2	358.97 Million EUR	20.8%
2017 Q3	124.61 Million EUR	9.23%
2017 Q2	114.08 Million EUR	-6.56%
2017 Q4	297.8 Million EUR	138.99%
2017 FY	297.8 Million EUR	147.45%
2017 Q1	122.09 Million EUR	1.45%
2016 Q2	49.54 Million EUR	0.0%
2016 Q1	- EUR	-100.0%
2016 FY	120.35 Million EUR	181.38%
2016 Q4	120.35 Million EUR	102.43%
2016 Q3	59.45 Million EUR	20.01%
2015 Q1	- EUR	0.0%
2015 Q4	42.77 Million EUR	0.0%
2015 FY	42.77 Million EUR	44.95%
2014 FY	29.5 Million EUR	14.73%
2013 FY	25.72 Million EUR	0.0%

Peer Total Assets Comparison of Redcare Pharmacy NV

Name	Total Assets	Total Assets Difference
Newron Pharmaceuticals S.p.A.	25.87 Million EUR	-3952.44%